Using imaging to tell real tumor growth from treatment effects
Part of Brain & nervous system, Cancer clinical trials.
This trial uses special imaging to tell the difference between real brain tumor growth and a treatment reaction that looks like a tumor. It may help you and your doctor decide if a biopsy is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been treated for a brain tumor before and now have a new suspicious finding on a scan that needs to be checked further.
- You are willing to have a biopsy (a small tissue sample taken) to help determine if the finding is true tumor growth or a treatment-related change.
- You are willing to have an MRI or CT scan with contrast dye within 14 days before the biopsy (preferably within 3 days).
- Your kidneys work well enough (GFR of 30 or higher for MRI contrast, or 45 or higher for CT contrast) to safely receive the contrast dye.
- You do not have any metal implants or devices that are not safe for MRI, or if you do, they are approved for MRI scanning.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether advanced brain MRI images can help doctors choose the best spot to biopsy suspected or proven primary brain tumors. It may help make biopsies safer and more accurate before tissue diagnosis.
This study tests whether imaging scans can be timed based on your symptoms and progress, rather than on a fixed schedule. The goal is to make monitoring easier while keeping you safe during standard brain cancer treatment.
This study is testing whether special MRI scans and blood tests can help tell the difference between true tumor growth (progression) and a treatment-related reaction called 'pseudoprogression' in people with glioblastoma. The goal is to make treatment decisions more accurate.
This trial tests a new kind of PET scan that uses a special tracer (Zr-89 crefmirlimab berdoxam) to help doctors see brain tumors more clearly before surgery. If you are scheduled to have your brain tumor removed, this scan may give your surgeon extra information to guide the operation.
This trial tests whether a special PET scan can tell the difference between actual tumor growth and treatment-related changes in people with aggressive brain cancer (high-grade glioma). If you have had radiation and an MRI shows a growing lesion, this study may help clarify the cause.
This trial studies a special imaging scan that combines MRI and PET to find active tumor areas in patients with glioblastoma. It aims to see if the scan can help identify the most aggressive parts of the tumor for surgery.
Hear when a new Brain Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.